Page 9 - NIS English December16-31
P. 9

MEETING WITH CMs OF EIGHT STATES OVER VACCINE DISTRIBUTION


            lChief Ministers of eight states were asked to
              review   status, preparedness of COVID-19
              response  and management. They assured
              that  the  way  focus  in  the  fight  against
              COVID-19 has been on saving  every life, the
              priority will be to ensure that vaccine reaches
              everyone
            lThe meeting, held  via video  conferencing,        Force to ensure better results
              had chief ministers of Haryana, Delhi,         l So far, India has more than 28,000 cold chain
              Chhattisgarh,     Kerala,     Maharashtra,        points and is working to increase the number
              Rajasthan, Gujarat and West Bengal             l To track each vaccine,  a digital  platform  is
            lThis was the Prime Minister’s 11th meeting         being  prepared and  tested. This will  track
              with the Chief Ministers on the issue             each and every step of the vaccine from its
            lThe Prime Minister noted that priority of          exit from the company till it reaches the people
              vaccination is being decided in consultation   l Priority for vaccination  will be given to
              with the States                                   healthcare, frontline and all those workers
            lRequirements  of additional  cold  chain           who are at the risk of infection
              storages have also been discussed with the     l  Procurement of the syringe is also in the last
              States                                            stage
            lHe asked the Chief Ministers to ensure
              regular monitoring of  State  Level Steering               (Scan QR Code to hear the Prime
              Committee and State and District Level Task                     Minister's full address)

                                   Vaccine trial in final stage


                    Covishield                          NO LAXITY UNTIL THERE IS A CURE             Government
                                                                                                    Laboratory
                                                     94.28 % 1.45 %
                   Early results found to be        Recovery Rate  Death Rate  4,09,689 96,08,211    1,187
                   effective up to 90%                                   Active cases Total patient  Private
                                                             PATIENTS CURED SO FAR - 90,58,822        1,012
        n The Serum Institute of India, along with Oxford                             (Data up to  5 December 2020)
          University and AstraZeneca, has created the   Vaccination of 31 Crore people in the first phase…
          vaccine (Covishield). Serum said an application   l  According to Principal Scientific Advisor  K. Vijayaraghavan, the
          for emergency use would be made within two
          weeks in India.                              National Vaccine Committee headed by Dr. VK Paul has prepared
                                                       a blueprint that who will be the first to be vaccinated
                     Covaxin                         l  In a meeting of the Ministry of Science and The Confederation

                  Phase-3 trials of Covaxin have       of Indian Industry, he informed  that 31 Crore people have been
                  started in about 25 locations.       identified to be vaccinated between March and May
        n It has been developed by Bharat Biotech of   l   Vijayaraghavan said, 'The vaccine will be given first to One crore
          Hyderabad in association with the National   health workers, police force of states and central government,
          Institute of Virology and the Indian Council of
          Medical Research. The target is to launch the   armed jawans, home guards, 26 crore members of priority group
          vaccine by the first quarter of 2021         above 50 years and high risk group below 50 year

           Zydus Cadila         The vaccine of Ahmedabad-based Zydus Cadila Healthcare is also in the
                                second phase. Cadila Healthcare vaccine results will be revealed soon. It
             Healthcare         is expected that this vaccine will also be available by April 2021.

                                                                                  New India Samachar 7
   4   5   6   7   8   9   10   11   12   13   14